Ensitrelvir

Chemical formula: C₂₂H₁₇ClF₃N₉O₂  PubChem compound: 162533924

Therapeutic indications

Ensitrelvir is indicated for:

Post-exposure prophylaxis of COVID-19

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Ensitrelvir is indicated for the post-exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years and older.

Ensitrelvir should be used in accordance with official recommendations.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Ensitrelvir is contraindicated in the following cases:

Pregnancy

Pregnancy

Potent CYP3A inducers

at least one of
Strong potency CYP3A4 inducers
Cytochrome P-450 CYP3A5 strong inducers

Medicinal products that are highly dependent on CYP3A for clearance

at least one of
Ranolazine
Dronedarone
Quinidine
Venetoclax
Colchicine
Terfenadine
Lurasidone
Pimozide
Quetiapine
Ticagrelor
Eplerenone
Ivabradine
Mavacamten
Dihydroergotamine
Ergotamine
Methergine
Cisapride
Voclosporin
Simvastatin
Lovastatin
Lomitapide
Finerenone
Cariprazine
Naloxegol
Avanafil
Tadalafil
Vardenafil
Daridorexant
Midazolam
Triazolam
CYP3A4 substrates

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈